Immunocore Holdings plc
IMCR$1.50B
Small CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaOXFORDSHIRE
Drugs in Pipeline
5
Phase 3 Programs
2
Upcoming Catalysts
3
Next Catalyst
Aug 6, 2026
6wMarket Overview
Stock performance and key metrics
IMCR News
Catalyst Timeline
3 upcoming, 1 past
Drug Pipeline
Brenetafusp
Select Advanced Solid Tumors
Tebentafusp
Advanced Melanoma
IMC-R117C
Cancer
Dacarbazine
Uveal Melanoma
IMCgp100
Uveal Melanoma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Brenetafusp | Phase 3 | Select Advanced Solid Tumors | - | - |
Tebentafusp | Phase 3 | Advanced Melanoma | - | - |
IMC-R117C | Phase 2 | Cancer | - | - |
Dacarbazine | Phase 2 | Uveal Melanoma | - | - |
IMCgp100 | Phase 2 | Uveal Melanoma | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply